FDANonrulemakingFDA-2024-D-5374
Who commented on this docket
Considerations for Complying With 21 CFR 211.110; Draft Guidance for Industry; Availability
1 organizations filed 1 public comment on Considerations for Complying With 21 CFR 211.110; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 477d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 477d ago
Abstract
OPEN
Commenters (1)
- Parenteral Drug Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.